Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy
Authors
Keywords
Eyes, Lesions, Vision, Tomography, Visual acuity, Growth factors, Hemorrhage, Ocular anatomy
Journal
PLoS One
Volume 16, Issue 3, Pages e0248760
Publisher
Public Library of Science (PLoS)
Online
2021-03-24
DOI
10.1371/journal.pone.0248760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions
- (2020) Hidetaka Matsumoto et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy
- (2020) Yoko Kitajima et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Pachychoroid disease: a new perspective on exudative maculopathy
- (2020) Yasuo Yanagi JAPANESE JOURNAL OF OPHTHALMOLOGY
- Features of neovascularization in pachychoroid neovasculopathy compared with type 1 neovascular age-related macular degeneration on optical coherence tomography angiography
- (2020) Serra Arf et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
- (2020) Benedikt Schworm et al. Scientific Reports
- Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum—pathogenesis, imaging and available treatment options
- (2020) Francesco Sartini et al. INTERNATIONAL OPHTHALMOLOGY
- Hypothetical pathogenesis of age-related macular degeneration and pachychoroid diseases derived from their genetic characteristics
- (2020) Kenji Yamashiro et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
- (2019) Byung Ju Jung et al. Scientific Reports
- Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept
- (2018) Chikako Hara et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Pachychoroid disease
- (2018) Chui Ming Gemmy Cheung et al. EYE
- CHOROIDAL VASCULAR HYPERPERMEABILITY AS A PREDICTOR OF TREATMENT RESPONSE FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
- (2017) Yasuo Yanagi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2017) Adrian Koh et al. JAMA Ophthalmology
- Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
- (2016) E Smretschnig et al. EYE
- ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID
- (2016) Jae Hyung Lee et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PACHYCHOROID NEOVASCULOPATHY
- (2015) Claudine E. Pang et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Pachychoroid neovasculopathy and age-related macular degeneration
- (2015) Masahiro Miyake et al. Scientific Reports
- ONE-YEAR CHOROIDAL THICKNESS RESULTS AFTER PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY
- (2011) Ichiro Maruko et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Efficacy of Intravitreal Bevacizumab Combined With Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2010) Fumi Gomi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
- (2009) WAI-MAN CHAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search